MRI Fusion Biopsy vs. Micro-Ultrasound Guided Biopsy

Running, not enrolling

Conditions studied: Prostate Cancer

In brief

The purpose of this study is to find out how best to detect clinically significant lesions of prostate cancer by using micro-ultrasound technology (ExactVu) and by multiparametric magnetic-resonance imaging (mpMRI).

Key facts

Study ID

NCT05471128

Run by

University of Oklahoma

People needed

29

Starts

2023-01-27

Expected to finish

2026-06-01

Last updated by the study team

2026-02-10

Who can join

Age: 18 and older, up to 99. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Patients scheduled to undergo biopsy and with one of the following:
• Men with suspicion of prostate cancer
• Men on active surveillance
• Age ≥18 [30]
• Have available multiparametric prostate MRI
• Able to provide written, informed consent
• No significant medical illness which in the opinion of the Investigator would preclude entry to study procedures
• Be willing and able to comply with scheduled visits

You may not qualify if…

• Previously confirmed prostate cancer diagnosis with Grade Group >= 2
• Unable to undergo prostate biopsy
• Prostate MRI unable to be evaluated using the PI-RADS v2 criteria
• Men with contraindication for MRI or a prostate biopsy
• Prostate biopsy within 8 weeks prior to mpMRI.
• Any history of prostate treatment

Where it is running

• University of Oklahoma Health Sciences Center, Stephenson Cancer Center — Oklahoma City, Oklahoma, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.